Literature DB >> 16163604

[Occupational and non-occupational risk factors in bladder cancer patients in an industrialized area located in former East-Germany].

K Golka1, T Seidel, H Dietrich, G Roth, C Rötzel, R Thier, F Geller, T Reckwitz, H Schulze.   

Abstract

PURPOSE: Several occupational carcinogens are metabolized by polymorphic enzymes. The distribution of the polymorphic enzymes N-acetyltransferase 2 (NAT2; substrates: aromatic amines), glutathione S-transferase M1 (GSTM1; substrates: e. g., reactive metabolites of polycyclic aromatic hydrocarbons), and glutathione S-transferase T1 (GSTT1; substrates: small molecules with 1 - 2 carbon atoms) were investigated.
MATERIAL AND METHODS: At the urological department in Lutherstadt Wittenberg, 136 patients with a histologically proven transitional cell cancer of the urinary bladder were investigated for all occupations performed for more than 6 months. Several occupational and non-occupational risk factors were asked. The genotypes of NAT2, GSTM1, and GSTT1 were determined from leucocyte DNA by PCR.
RESULTS: Compared to the general population in Middle Europe, the percentage of GSTT1 negative persons (22.1 %) was ordinary; the percentage of slow acetylators (59.6 %) was in the upper normal range, while the percentage of GSTM1 negative persons (58.8 %) was elevated in the entire group. Shifts in the distribution of the genotypes were observed in subgroups who had been exposed to asbestos (6/6 GSTM1 negative, 5/6 slow acetylators), rubber manufacturing (8/10 GSTM1 negative), and chlorinated solvents (9/15 GSTM1 negative).
CONCLUSIONS: The overrepresentation of GSTM1 negative bladder cancer patients also in this industrialized area and more pronounced in several occupationally exposed subgroups points to an impact of the GSTM1 negative genotype in bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16163604     DOI: 10.1055/s-2004-830260

Source DB:  PubMed          Journal:  Aktuelle Urol        ISSN: 0001-7868            Impact factor:   0.658


  9 in total

1.  Re-assessment of the influence of polymorphisms of phase-II metabolic enzymes on renal cell cancer risk of trichloroethylene-exposed workers.

Authors:  Bernd Wiesenhütter; Silvia Selinski; Klaus Golka; Thomas Brüning; Hermann M Bolt
Journal:  Int Arch Occup Environ Health       Date:  2007-05-04       Impact factor: 3.015

Review 2.  [Occupation-related cancer in urology-Current knowledge including environmental medical aspects].

Authors:  Klaus Golka; Ralf Böthig; Wobbeke Weistenhöfer; Olaf P Jungmann; Steffi Bergmann; Michael Zellner; Wolfgang Schöps
Journal:  Urologie       Date:  2022-09-26

3.  Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis.

Authors:  Fang-Fang Zeng; Sheng-Yuan Liu; Wen Wei; Song-Po Yao; Shui Zhu; Ke-Shen Li; Gang Wan; Hai-Tao Zhang; Min Zhong; Bin-You Wang
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

Review 4.  Glutathione S-transferases in kidney and urinary bladder tumors.

Authors:  Tatjana Simic; Ana Savic-Radojevic; Marija Pljesa-Ercegovac; Marija Matic; Jasmina Mimic-Oka
Journal:  Nat Rev Urol       Date:  2009-05       Impact factor: 14.432

Review 5.  [Influence of obesity on urological malignancies].

Authors:  H Eggers; M A Kuczyk; A J Schrader; S Steffens
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

6.  The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.

Authors:  Yajie Yu; Xiao Li; Chao Liang; Jingyuan Tang; Zhiqiang Qin; Chengming Wang; Weizhang Xu; Yibo Hua; Pengfei Shao; Ting Xu
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.

Authors:  Tianbiao Zhou; Hong-Yan Li; Wei-Ji Xie; Zhiqing Zhong; Hongzhen Zhong; Zhi-Jun Lin
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430

8.  Associations of GSTM1*0 and GSTA1*A genotypes with the risk of cardiovascular death among hemodialyses patients.

Authors:  Sonja Suvakov; Tatjana Damjanovic; Tatjana Pekmezovic; Jovana Jakovljevic; Ana Savic-Radojevic; Marija Pljesa-Ercegovac; Slavica Radovanovic; Dragan V Simic; Steva Pljesa; Milos Zarkovic; Jasmina Mimic-Oka; Nada Dimkovic; Tatjana Simic
Journal:  BMC Nephrol       Date:  2014-01-14       Impact factor: 2.388

9.  GSTT1 Null Genotype Significantly Increases the Susceptibility to Urinary System Cancer: Evidences from 63,876 Subjects.

Authors:  Ying Wang; Jing He; Tian-Jiao Ma; Wei Lei; Feng Li; Han Shen; Zhen-Ya Shen
Journal:  J Cancer       Date:  2016-07-26       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.